April 20, 2016

Icare measures further success in USA

The device is to gradually replace the Icare TA01 tonometer.
The device is to gradually replace the Icare TA01 tonometer.
Revenio

The United States Food and Drug Administration FDA has granted Icare Finland a permit to sell its next-generation Icare ic100 tonometer on the US market.

The device is being introduced to gradually replace the Icare TA01 tonometer, which was first released by Revenio in 2003. The company has had a presence in the US since 2007.

The tonometer offers quick, easy and painless eye pressure measurement by ophthalmologists, optometrists and emergency departments, without requiring anesthesia or air.

Elsewhere, the Icare ic100 tonometer was earlier awarded with a CE mark in Europe and sales have begun in the region. Revenio has also acquired sales permits for the device in Australia and South Africa.

Looking for more good news? Subscribe to our newsletter

Share: